October 25, 2023 — Elixir Medical, developer of novel cardiovascular technologies, announced positive six-month clinical data from the DESyne BDS Plus Randomized Controlled Trial (RCT) during the Transcatheter Cardiovascular Therapeutics (TCT) conference, TCT 2023, in San Francisco, CA.

October 25, 2023 — Edwards Lifesciences announced new data from the PARTNER 3 trial demonstrating continued low rates of all-cause mortality, disabling stroke and rehospitalization at five years.

October 25, 2023 — Data from the REAL-PE study was presented today at Transcatheter Cardiovascular Therapeutics(TCT), the annual scientific symposium of the Cardiovascular Research Foundation, demonstrating that patients treated for pulmonary embolism (PE) with the Boston Scientific 

October 25, 2023 — Shockwave Medical, Inc., a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, announced that two new publications reported excellent and consistent outcomes with coronary intravascular lithotripsy (IV

October 25, 2023 — ConcertAI's TeraRecon, a leader in advanced visualization and artificial intelligence (AI) for medical imaging, will showcase its latest innovations and cardiology solutions designed to strengthen clinical confidence, build efficiency throughout the care pathway, and improve cardiac care experiences at the 

October 25, 2023 — Findings from a trial led by Cleveland Clinic show that patients with atrial fibrillation undergoing a transcatheter aortic valve replacement (TAVR) at the same time as a left atrial appendage occlusion (LAAO) procedure using the 

October 25, 2023 — Information on a new double lumen catheter was presented by Nabil Dib, MD, MSc, FACC, FESC, during the 2023 Transcatheter Cardiovascular Therapeutics conference, TCT 2023, being held Oct. 23-26 in San Francisco, CA.

October 25, 2023 — For its novel multi-lumen stent system for interventional adjustment of pulmonary blood flow in congenital heart disease, INTELLISENT, Heart Point Global, Inc. was the winner in the Shark Tank Innovation Competition at the Transcatheter Cardiovascular Therapeutics (TCT) conference in San Francisco, CA, held during the October 23 MedTech Innovation Forum


In a new 3-part video series on hypertrophic cardiomyopathy with Christine E. Seidman, MD, FACC, FAHA, Managing Editor Christine Book sat down with the cardiovascular research leader to learn more about the critical work and research she is conducting in this field.


Subscribe Now